• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接受单纯保乳手术治疗的导管原位癌女性患者的基于人群队列中,局部复发的预测因素。

Predictors of local recurrence in a population-based cohort of women with ductal carcinoma in situ treated with breast conserving surgery alone.

机构信息

Radiation Therapy Program, BC Cancer Agency-Vancouver Island Centre, Victoria, BC, Canada.

出版信息

Ann Surg Oncol. 2011 Jan;18(1):119-24. doi: 10.1245/s10434-010-1214-x. Epub 2010 Jul 20.

DOI:10.1245/s10434-010-1214-x
PMID:20645008
Abstract

BACKGROUND

To identify prognostic indicators of local recurrence (LR) in patients with ductal carcinoma in situ (DCIS) of the breast treated with breast conserving surgery (BCS) alone.

METHODS

A retrospective study was conducted of all women with pure DCIS, diagnosed 1985-1999, referred for tertiary oncologic opinion in British Columbia, treated with BCS without adjuvant radiotherapy. Kaplan-Meier local control (LC) and breast cancer specific survival (BCSS) estimates for the entire group were plotted. Stratified analyses identified subgroups with high Kaplan-Meier 10-year LR. Cox multivariate modeling was used to assess predictors of LR. Kaplan-Meier BCSS rates were compared between two cohorts: those who experienced LR and those who did not have LR.

RESULTS

A total of 460 women comprised the study cohort. Median follow-up was 9.4 years. The 15-year LC and BCSS rates were 82% and 97%, respectively. Stratified analyses of LR identified comedo histology, high nuclear grade, tumor size >4 cm or indeterminate size, and positive margins to be associated with significantly higher LR risk, with 10-year LR risks approximating 15-30%. The 10-year BCSS rates for the LR group were 94% compared with 99% for the NoLR group. On Cox regression modeling, high nuclear grade, the presence of comedocarcinoma, and positive margins were significant factors for higher risk of LR.

CONCLUSIONS

Women with DCIS treated with BCS alone had higher LR risk, and those with a LR were more likely to die of breast cancer. Optimal local treatment is mandatory to minimize the risk of breast cancer death for women with this curable disease.

摘要

背景

为了确定接受保乳手术(BCS)治疗的乳腺导管原位癌(DCIS)患者局部复发(LR)的预后指标。

方法

对所有 1985-1999 年在不列颠哥伦比亚省被转诊至三级肿瘤专科接受治疗的、接受单纯 BCS 治疗且未接受辅助放疗的乳腺纯 DCIS 女性患者进行回顾性研究。对整个组别的 Kaplan-Meier 局部控制(LC)和乳腺癌特异性生存(BCSS)进行了评估。分层分析确定了 Kaplan-Meier 10 年 LR 较高的亚组。使用 Cox 多变量模型评估 LR 的预测因子。比较了发生 LR 和未发生 LR 的两组之间的 Kaplan-Meier BCSS 率。

结果

共有 460 名女性入组该研究队列。中位随访时间为 9.4 年。15 年的 LC 和 BCSS 率分别为 82%和 97%。LR 的分层分析确定了粉刺样组织学、高核分级、肿瘤大小>4cm 或不确定大小、以及阳性切缘与显著较高的 LR 风险相关,10 年 LR 风险接近 15%-30%。LR 组的 10 年 BCSS 率为 94%,而无 LR 组为 99%。在 Cox 回归模型中,高核分级、粉刺癌和阳性切缘是 LR 风险较高的显著因素。

结论

接受单纯 BCS 治疗的 DCIS 女性患者 LR 风险较高,且发生 LR 的患者更有可能死于乳腺癌。为了降低这种可治愈疾病患者死于乳腺癌的风险,必须采用最佳的局部治疗方法。

相似文献

1
Predictors of local recurrence in a population-based cohort of women with ductal carcinoma in situ treated with breast conserving surgery alone.在接受单纯保乳手术治疗的导管原位癌女性患者的基于人群队列中,局部复发的预测因素。
Ann Surg Oncol. 2011 Jan;18(1):119-24. doi: 10.1245/s10434-010-1214-x. Epub 2010 Jul 20.
2
Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.乳头溢液相关乳腺癌患者保乳手术的可行性
Cancer. 2004 Aug 1;101(3):508-17. doi: 10.1002/cncr.20394.
3
Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.接受保乳治疗或乳房切除术的乳腺导管原位癌患者局部复发及特定病因生存率的相关因素。
Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1514-21. doi: 10.1016/j.ijrobp.2005.04.045. Epub 2005 Jul 11.
4
Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.保乳手术和放疗作为乳腺钼靶检测到的乳腺导管原位癌的初始治疗后局部复发的挽救性治疗。
Cancer. 2001 Mar 15;91(6):1090-7.
5
Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis.能否筛选出低风险导管原位癌(DCIS)患者?基于人群的结局分析。
Breast Cancer Res Treat. 2013 Apr;138(2):581-90. doi: 10.1007/s10549-013-2455-8. Epub 2013 Mar 3.
6
Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.经乳房钼靶检查发现、临床隐匿的导管原位癌,采用保乳手术及根治性乳房放疗进行治疗。
Cancer J Sci Am. 1996 May-Jun;2(3):158-65.
7
Ductal carcinoma in situ of the breast: influence of age on diagnostic, therapeutic, and prognostic features. Retrospective study of 812 patients.乳腺导管原位癌:年龄对诊断、治疗和预后特征的影响。812 例患者的回顾性研究。
Ann Surg Oncol. 2011 May;18(5):1372-9. doi: 10.1245/s10434-010-1441-1. Epub 2010 Nov 25.
8
Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.保乳手术后切缘接近或局灶受累的乳腺导管原位癌:再次切除或增加剂量放疗的治疗方法
Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1021-8. doi: 10.1016/j.ijrobp.2008.12.014. Epub 2009 Apr 20.
9
The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis.DCIS保乳手术后同侧第二原发肿瘤的发生率:一项基于人群的分析。
Cancer. 2005 Nov 1;104(9):1840-8. doi: 10.1002/cncr.21406.
10
Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history.导管原位癌保守手术及放疗后的局部复发:家族史的潜在重要性
Cancer J Sci Am. 1995 May-Jun;1(1):55-61.

引用本文的文献

1
Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study.DCIS 大小和边缘状态与治疗后乳腺癌发病风险的关系:多国、汇总队列研究。
BMJ. 2023 Oct 30;383:e076022. doi: 10.1136/bmj-2023-076022.
2
A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast.乳腺导管原位癌主动监测试验的回顾性替代方法。
Int J Cancer. 2020 Mar 1;146(5):1189-1197. doi: 10.1002/ijc.32362. Epub 2019 May 8.
3
Effect of Referral Patterns and Treatment Type on Oncologic Outcomes for Women with Ductal Carcinoma In Situ.
转诊模式和治疗类型对导管原位癌女性肿瘤学结局的影响。
Cureus. 2017 Mar 31;9(3):e1128. doi: 10.7759/cureus.1128.
4
Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast.表征乳腺高危导管原位癌中的免疫微环境。
Breast Cancer Res Treat. 2017 Jan;161(1):17-28. doi: 10.1007/s10549-016-4036-0. Epub 2016 Oct 26.
5
Relationship Between Margin Width and Recurrence of Ductal Carcinoma In Situ: Analysis of 2996 Women Treated With Breast-conserving Surgery for 30 Years.导管原位癌切缘宽度与复发的关系:对2996例行保乳手术治疗30年的女性患者的分析
Ann Surg. 2015 Oct;262(4):623-31. doi: 10.1097/SLA.0000000000001454.
6
A Comparison of Tumor Biology in Primary Ductal Carcinoma In Situ Recurring as Invasive Carcinoma versus a New In Situ.原发性导管原位癌复发为浸润性癌与新发原位癌的肿瘤生物学比较
Int J Breast Cancer. 2013;2013:582134. doi: 10.1155/2013/582134. Epub 2013 Dec 29.